The recall rate of screening mammography is reduced when radiologists compare with more than one prior mammogram, a study published in the October 2016 issue of the American Journal of Roentgenology said.

Much has been said about the potential of outcomes to change the practice of medicine. Through comparative studies, outcomes research could point out how, under certain circumstances, the use of one imaging technology might be better than others. It might simplify the choice and process by which referring physicians order exams, encouraging best practices not only in the choice of a modality but in the use of specific scan protocols.

November 9, 2016 — Teleradiology Solutions (TRS) announced it was selected by Massachusetts General Hospital (MGH) in Boston to perform remote 3-D post-processing services.

Toshiba America Medical Systems Inc. and Applied Radiology are inviting attendees at the 2016 annual meeting of the Radiological Society of North America (RSNA) to expert-led forums on the latest advances in computed tomography (CT) imaging and interventional radiology.

Rayence Inc. announced today their parent company, Rayence Co. Ltd., acquired Miami-based Osko Digital X-ray Solutions. The purchase was said to have been completed in late September.

Volpara Solutions announced the launch of a support program to help accredited breast imaging centers across the United States prepare for compliance to the U.S. Food and Drug Administration’s (FDA) Enhancing Quality Using the Inspection Program (EQUIP) initiative. The Volpara "EQUIP-ready" program — which includes draft processes, procedures and forms designed to help users accelerate their compliance efforts — is included with the company's Volpara Enterprise cloud-based quality assurance solution.

At this year’s annual meeting of the Radiological Society of North America (RSNA 2016), ContextVision will demonstrate its wide range of imaging enhancement software solutions for ultrasound, X-ray-based modalities and magnetic resonance imaging (MRI).

The National Comprehensive Cancer Network (NCCN) is collaborating with MedCurrent to integrate the NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC) into its clinical decision support (CDS) platform, OrderWise. The integration will allow access to imaging recommendations as derived from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines).

Utah-based healthcare technology company Novarad has recently received U.S. Food and Drug Administration (FDA) 510(K) clearance of its MobileRad native iPad application, which is now available on the App Store.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now